Al-Qahtani Saeed, Al-Afraj Khalid, Al-Jindan Mohanna, Al-Beshri Ali S, Khandekar Rajiv
Department of Surgery, Faculty of Medicine, Najran University, Najran 61441, Saudi Arabia.
Department of Ophthalmology, Dammam University, Dammam 34464, Saudi Arabia.
Int J Ophthalmol. 2018 May 18;11(5):888-890. doi: 10.18240/ijo.2018.05.27. eCollection 2018.
This cohort study included 36 eyes of 21 patients with high myopia treated with angle supported phakic intraocular lens (pIOL). Endothelial cell density (ECD) at baseline, 6mo and 3y were 3017±296, 2775±265 and 2558±299 cells/mm respectively. ECD loss at 6mo was 7.2% and annual ECD loss was 3% over 36mo. Corrected distance visual acuity at 36mo was 0.4 logMAR or better in 32 (88.9%) eyes. Intraocular pressure did not change (=0.9). No eyes developed cataract, retinal detachment or pupillary distortion. Angle supported pIOL gives good visual outcome. Endothelial cell loss should be monitored.
这项队列研究纳入了21例高度近视患者的36只眼，采用有晶体眼人工晶状体（pIOL）植入术进行治疗。基线、6个月和3年时的内皮细胞密度（ECD）分别为3017±296、2775±265和2558±299个细胞/mm²。6个月时ECD损失率为7.2%，36个月期间ECD年损失率为3%。36个月时，32只眼（88.9%）的矫正远视力为0.4 logMAR或更好。眼压无变化（P=0.9）。无眼发生白内障、视网膜脱离或瞳孔变形。有晶体眼人工晶状体植入术可带来良好的视觉效果。应监测内皮细胞损失情况。
